In today's world, heart disease threatens human life owing to higher mortality and morbidity across the globe. The earlier prediction of heart disease engenders interoperability for the treatment of patients and offers better diagnostic recommendations from medical professionals. However, the existing machine learning classifiers suffer from computational complexity and overfitting problems, which reduces the classification accuracy of the diagnostic system. To address these constraints, this work proposes a new hybrid optimization algorithm to improve the classification accuracy and optimize computation time in smart healthcare applications. Primarily, the optimal features are selected through the hybrid Arithmetic Optimization and Inter-Twinned Mutation-Based Harris Hawk Optimization (AITHO) algorithm. The proposed hybrid AITHO algorithm entails advantages of both exploration and exploitation abilities and acquires faster convergence. It is further employed to tune the parameters of the Stabilized Adaptive Neuro-Fuzzy Inference System (SANFIS) classifier for predicting heart disease accurately. The Cleveland heart disease dataset is utilized to validate the efficacy of the proposed algorithm. The simulation is carried out using MATLAB 2020a environment. The simulation results show that the proposed hybrid SANFIS classifier attains a superior accuracy of 99.28% and true positive rate of 99.46% compared to existing state-of-the-art techniques.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/0954898X.2024.2404915 | DOI Listing |
Heart Fail Rev
January 2025
Department of Anesthesiology and Critical Care, Université Paris Cité, Paris, France.
Heart failure (HF), a chronic and progressive disease, is increasing in prevalence worldwide and is associated with increased hospitalizations and death. Despite notable improvements in medical therapy for HF, patients are still at risk of future negative outcomes. Current guidelines recommend four classes of medication for treating patients with HF, deemed guideline-directed medical therapy (GDMT).
View Article and Find Full Text PDFHeart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are increasingly prevalent cardiovascular conditions, particularly among the elderly population. These two conditions share common risk factors and often coexist, leading to a complex interplay that alters the clinical course of each other. The pathophysiology of HFpEF is multifaceted and intricately linked, with atrial disease serving as a common pathophysiological pathway.
View Article and Find Full Text PDFWorld J Pediatr
January 2025
Cardiac Arrhythmia Center, National Center for Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 167 Beilishi Road, Xicheng District, Beijing, 100037, China.
Background: Heart failure (HF) significantly impacts the cardiovascular health of children and adolescents. This study aims to assess epidemiologic trends in HF across sex, age, region, and time period.
Methods: The number and age-standardized rate (ASR) of prevalence and years lived with disability (YLDs) were derived from the Global Burden of Disease Study 2019.
Nat Rev Cardiol
January 2025
Stanford Cardiovascular Institute, Stanford, CA, USA.
Cannabis has been consumed for centuries, but global regulatory changes over the past three decades have increased the availability and consumption of cannabis. Cannabinoids are touted to have therapeutic potential for many diseases and could be a replacement for opioids for analgesia and sedation. However, cannabinoids can cause substantial adverse cardiovascular events that would mitigate any potential benefit.
View Article and Find Full Text PDFPediatr Cardiol
January 2025
Division of Pediatric Cardiology, Department of Pediatrics, Hasbro Children's Hospital, The Warren Alpert Medical School at Brown University, Providence, RI, USA.
Prenatal diagnosis of congenital heart disease requiring early cardiac catheterization or surgical intervention enables optimal delivery planning for appropriate postnatal cardiovascular intervention and care. This allows for improved morbidity and mortality. Prior national data reported prenatal diagnosis rates of 32% for congenital heart disease requiring intervention in infants in the first 6 months of life in the New England region.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!